Last edition
News about
Zydus Cadila gets US FDA tentative marketing nod for epilepsy drug, brivaracetam
Zydus Cadila has received tentative approval from the US FDA to market brivaracetam tablets, in the strengths of 10 mg, 25 mg, 50 mg, 75 mg, and 100 mg. Brivaracetam is used to treat partial-onset of seizures (epilepsy).
CSIR-CDRI signs agreement with Marc Labs to develop drug for heart attack and stroke
The agreement has been signed for the development of a synthetic compound S-007-867 as modulator of blood coagulation cascade, in particular as inhibitor of collagen induced platelet aggregation. This may be helpful in treating patient population of coronary and cerebral artery diseases
CSIR-IICT, Lee Pharma sign agreement to produce 2-D
Lee Pharma has entered into a non-exclusive licensing agreement with the Indian Institute of Chemical Technology (IICT), a constituent laboratory of CSIR, to manufacture and commercialise 2-Deoxy-D-Glucose (2-DG) recently developed by DRDO and Dr Reddy's Laboratories to treat COVID patients, informed a statement
DRDO invites EoI to transfer technology of 2-DG drug for bulk production
The Defence Research and Development Organisation (DRDO), which developed 2-Deoxy-D-Glucose (2-DG), a drug used for treatment of Covid-19 patients, has called for Expression of Interest (EoI) to transfer the technology to Indian pharmaceutical industries for production
CMO Selkirk blueprints $90M factory to help bring injectable drug manufacturing stateside
Even as the pandemic winds down in the U.S., the push to bring drug manufacturing stateside persists. Privately held contract manufacturer Selkirk Pharma is teeing up a flagship facility in Washington state to do just that
I Holland Present their Latest Tablet Tooling Developments at ACHEMA Pulse Next Week
I Holland, the world's best-known manufacturer of tablet punches and dies for the pharmaceutical and nutraceutical industries, has announced it will be exhibiting some of it most innovative products at ACHEMA Pulse from 15-19 June, including the new die table segment cleaning equipment
Roche gets CE mark for SARS-CoV-2 Antigen Self Test Nasal for at-home testing
Roche announced it has received CE mark for its SARS-CoV-2 Antigen Self Test Nasal for at-home testing. The test will be available in countries accepting the CE mark through pharmacies and other locations, in packs of five tests
Rockwell Industries, a commercial cold chain appliance manufacturer, has entered into a strategic partnership with Dr Reddy's Laboratories (DRL), to provide its WHO PQS (World Health Organisation - Performance, Quality and Safety) certified Covid-19 vaccine freezers to enable storage of Sputnik V vaccine across India
Glenmark Pharma releases interim data from PMS study on favipiravir
Glenmark Pharmaceuticals, a research-led, global integrated pharmaceutical company, announced interim data of 503 patients from its post marketing surveillance (PMS) study on favipiravir in India. The PMS study commenced in July 2020 aimed to evaluate safety and efficacy of favipiravir in mild to moderate Covid-19 patients
Final results from the head-to-head ELEVATE-RR phase III trial of AstraZeneca's Calquence (acalabrutinib) demonstrated non-inferior progression-free survival (PFS) and statistically significantly fewer events of atrial fibrillation versus ibrutinib in adults with previously treated chronic lymphocytic leukaemia (CLL), the most common type of leukaemia
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy